Ticker
RIGLCompany Name
RIGEL PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 434.8M | $ 2.52M | $ 0 | $ 0 | -0.58% |
3/31/2025 | $ 326.35M | $ 2.36M | $ 0 | $ 0 | -0.72% |
12/31/2024 | $ 394.41M | $ 1.96M | $ 0 | $ 0 | -0.5% |
9/30/2024 | $ 271.98M | $ 985K | $ 0 | $ 0 | -0.36% |
6/30/2024 | $ 164.16M | $ 836K | $ 0 | $ 0 | -0.51% |
3/31/2024 | $ 208.73M | $ 1.14M | $ 0 | $ 0 | -0.54% |
12/31/2023 | $ 259.56M | $ 1.05M | $ 19.95M | $ 0 | -8.09% |
9/30/2023 | $ 151.79M | $ 1.15M | $ 19.95M | $ 0 | -13.9% |
6/30/2023 | $ 231.9M | $ 1.14M | $ 29.55M | $ 0 | -13.23% |
3/31/2023 | $ 197.98M | $ 1.19M | $ 29.52M | $ 0 | -15.51% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for RIGEL PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 2.62M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 9.97M ]) / Market Cap [ $ 463.01M ]
(=) Shareholder Yield [ -2.72% ]
Minimum
Sep 30, 2022
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.56% |
median | 1.07% |
std | 11.12% |